D.E. Shaw & Co’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

D.E. Shaw & Co’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-272,750	Closed	-$15.3K	–	4787
2023 Q3	$15.3K	Hold	272,750	–	–	﹤0.01%	4018
2023 Q2	$39.6K	Hold	272,750	–	–	﹤0.01%	3906
2023 Q1	$21.8K	Hold	272,750	–	–	﹤0.01%	4132
2022 Q4	$8.18K	Hold	272,750	–	–	﹤0.01%	4628
2022 Q3	$22K	Hold	272,750	–	–	﹤0.01%	4798
2022 Q2	$16K	Hold	272,750	–	–	﹤0.01%	5064
2022 Q1	$60K	Buy	+272,750	New	+$70.8K	﹤0.01%	5102

D.E. Shaw & Co's BIOSW Position: Q4 2023 in Review

D.E. Shaw & Co sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 272,750 shares — an estimated $15.3K sold.

D.E. Shaw & Co first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $60K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

D.E. Shaw & Co reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
D.E. Shaw & Co sold 272,750 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $15.3K.
D.E. Shaw & Co first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
D.E. Shaw & Co's BioPlus Acquisition Corp. Warrants position peaked at $60K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.